BI

BVF Inc Portfolio holdings

AUM $2.8B
1-Year Return 17.96%
This Quarter Return
+34.37%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$893M
AUM Growth
+$128M
Cap. Flow
-$99.6M
Cap. Flow %
-11.15%
Top 10 Hldgs %
49.95%
Holding
59
New
4
Increased
15
Reduced
14
Closed
6

Top Buys

1
ACIU icon
AC Immune
ACIU
$26.4M
2
MRSN icon
Mersana Therapeutics
MRSN
$13.2M
3
CTMX icon
CytomX Therapeutics
CTMX
$12.9M
4
REPL icon
Replimune Group
REPL
$10.8M
5
VYGR icon
Voyager Therapeutics
VYGR
$5.94M

Top Sells

1
CCXI
ChemoCentryx, Inc.
CCXI
$72.5M
2
ARRY
Array Biopharma Inc
ARRY
$32.3M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.8M
4
XNCR icon
Xencor
XNCR
$18.4M
5
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$11.4M

Sector Composition

1 Healthcare 90.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BLRX
26
BioLineRX
BLRX
$15.1M
$11.2M 1.25%
43,326
– –
SNDX icon
27
Syndax Pharmaceuticals
SNDX
$1.39B
$10.4M 1.17%
1,987,669
– –
VSTM icon
28
Verastem
VSTM
$650M
$10.4M 1.16%
292,833
– –
ARGX icon
29
argenx
ARGX
$44.9B
$10.1M 1.13%
80,868
– –
FWP
30
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$10M 1.12%
1,211,440
– –
FSTX
31
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$9.98M 1.12%
237,925
– –
EIGR
32
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$9.44M 1.06%
22,500
– –
VBIV
33
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8.83M 0.99%
157,419
-16,476
-9% -$924K
CRVS icon
34
Corvus Pharmaceuticals
CRVS
$427M
$8.48M 0.95%
2,109,342
+218,835
+12% +$880K
MEIP icon
35
MEI Pharma
MEIP
$140M
$8.29M 0.93%
134,938
-13,997
-9% -$859K
ALPN
36
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$8.24M 0.92%
1,201,717
+558,658
+87% +$3.83M
CTIC
37
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$6.72M 0.75%
6,929,690
– –
ALBO
38
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$6.46M 0.72%
200,500
– –
VYGR icon
39
Voyager Therapeutics
VYGR
$215M
$5.94M 0.67%
+310,299
New +$5.94M
SPRO icon
40
Spero Therapeutics
SPRO
$120M
$5.9M 0.66%
460,706
-382,440
-45% -$4.9M
OVID icon
41
Ovid Therapeutics
OVID
$91.7M
$5.83M 0.65%
+3,293,000
New +$5.83M
PHXM
42
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.75M 0.53%
62,500
– –
GNCA
43
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.62M 0.52%
978,530
+339,223
+53% +$1.6M
CDTX icon
44
Cidara Therapeutics
CDTX
$1.65B
$4.53M 0.51%
85,534
-59,700
-41% -$3.16M
OMED
45
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4.27M 0.48%
4,108,815
+65,826
+2% +$68.5K
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.78M 0.31%
65,367
– –
FRTX
47
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$2.74M 0.31%
7,235
+3,153
+77% +$1.19M
RLM
48
DELISTED
Realm Therapeutics plc American Depositary Shares
RLM
$2.41M 0.27%
612,889
+252,023
+70% +$991K
SURF
49
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2.16M 0.24%
451,850
– –
EPIX icon
50
ESSA Pharma
EPIX
$11M
$1.99M 0.22%
580,368
– –
1
2
3